Development of a Clinical MALDI-ToF Mass Spectrometry Assay for SARS-CoV-2: Rational Design and Multi-Disciplinary Team Work

The COVID-19 pandemic caused by the SARS-CoV-2 coronavirus has stretched national testing capacities to breaking points in almost all countries of the world. The need to rapidly screen vast numbers of a country’s population in order to control the spread of the infection is paramount. However, the l...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Ray K. Iles, Raminta Zmuidinaite, Jason K. Iles, George Carnell, Alex Sampson, Jonathan L. Heeney
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Subjects:	biosecurity COVID-19 SARS-CoV-2 screening diagnostic test MALDI-ToF MS
Online Access:	https://www.mdpi.com/2075-4418/10/10/746